A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration
NCT01095497
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Hereditary Angioedema
Interventions
BIOLOGICAL:
CINRYZE
Sponsor
Shire